Hymenoptera-sting hypersensitivity

New England Journal of Medicine

Volumn 370, Issue 15, 2014, Pages 1432-1439

  Casale, Thomas B ^a   Burks, A Wesley ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BEE VENOM; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN E; VENOM; ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ANAPHYLAXIS; APIDAE; BEE STING; BUMBLEBEE; CASE REPORT; CLINICAL OBSERVATION; DIZZINESS; DYSPHAGIA; EMERGENCY WARD; FEMALE; FLUSHING; HONEYBEE; HUMAN; HYMENOPTERA; HYMENOPTERA STING HYPERSENSITIVITY; HYPERSENSITIVITY; IMMUNOTHERAPY; INSECT BITE; PRIORITY JOURNAL; REVIEW; SKIN TEST; SYMPTOMATOLOGY; UPPER LIP; URTICARIA; VESPIDAE; ANIMAL; DRUG ADMINISTRATION; PRACTICE GUIDELINE; YOUNG ADULT;

ANAPHYLAXIS; ANIMALS; DRUG ADMINISTRATION SCHEDULE; EPINEPHRINE; FEMALE; HUMANS; HYMENOPTERA; HYPERSENSITIVITY; INSECT BITES AND STINGS; PRACTICE GUIDELINES AS TOPIC; SYMPATHOMIMETICS; YOUNG ADULT;

EID: 84898755571     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1302681     Document Type: Article

References (46)

1. Freeman TM. Hypersensitivity to Hymenoptera stings. N Engl J Med 2004;351: 1978-84. (Pubitemid 39447139)
2. Hoffman DR, Dove DE, Jacobson RS. Allergens in Hymenoptera venom. XX. Isolation of four allergens from imported fire ant (Solenopsis invicta) venom. J Allergy Clin Immunol 1988;82:818-27. (Pubitemid 19003102)
3. Hoffman DR, Jacobson RS. Allergens in hymenoptera venom XII: how much protein is in a sting? Ann Allergy 1984; 52:276-8. (Pubitemid 14135382)
4. Hoffman DR. Hymenoptera venoms: composition, standardization, stability. In: Levine MI, Lockey RF, eds. Monograph on insect allergy. 4th ed. Milwaukee: American Academy of Allergy Asthma and Immunology, 2003:37-53.
5. King TP, Spangfort MD. Structure and biology of stinging insect venom allergens. Int Arch Allergy Immunol 2000; 123:99-106.
6. Golden DBK. Insect allergy. In: Adkinson NF, Busse WW, Bochner BS, et al., eds. Middleton's allergy: principles and practice. 7th ed. Philadelphia: Elsevier, 2009:1005-17.
7. Golden DB, Moffitt, JE, Nicklas RA, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011;127(4):852.e23-854.e23.
8. van der Linden PW, Hack CE, Struyvenberg A, van der Zwan JK. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis. J Allergy Clin Immunol 1994;94:151-9.
9. Brown SG, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind, placebo-controlled, cross-over trial. Lancet 2003;361:1001-6. (Pubitemid 36351369)
10. Franken HH, Dubois AE, Minkema HJ, van der Heide S, de Monchy JG. Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol 1994;93:431-6. (Pubitemid 24081783)
11. Reisman RE. Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions. J Allergy Clin Immunol 1992;90:335-9.
12. Bilò BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol 2008;8:330-7.
13. Golden DB, Marsh DG, Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA 1989;262:240-4. (Pubitemid 19176547)
14. Settipane GA, Boyd GK. Prevalence of bee sting allergy in 4,992 Boy Scouts. Acta Allergol 1970;25:286-91.
15. Settipane GA, Newstead GJ, Boyd GK. Frequency of Hymenoptera allergy in an atopic and normal population. J Allergy Clin Immunol 1972;50:146-50.
16. Light WC, Reisman RE, Shimizu M, Arbesman CE. Unusual reactions following insect stings: clinical features and immunologic analysis. J Allergy Clin Immunol 1977;59:391-7. (Pubitemid 8106149)
17. Schumacher MJ, Tveten MS, Egen NB. Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol 1994;93:831-5. (Pubitemid 24154098)
18. Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 2007;98:64-9. (Pubitemid 46106160)
19. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005;95:217-26.
20. Bilò MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy 2009;39:1467-76.
21. Simons FE, Ardusso LR, Bilò MB, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011; 4:13-37.
22. Korenblat P, Lundie MJ, Dankner R, Day JH. A retrospective study of the administration of epinephrine for anaphylaxis: how many doses are needed? Allergy Asthma Proc 1999;20:383-6.
23. Ruëff F, Przybilla B, Müller U, Mosbech H. The sting challenge test in Hymenoptera venom allergy. Allergy 1996;51: 216-25.
24. Golden DBK, Breisch NL, Hamilton RG, et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol 2006;117:670-5. (Pubitemid 43340234)
25. Reisman RE. Insect sting allergy: the dilemma of the negative skin test reactor. J Allergy Clin Immunol 2001;107:781-2. (Pubitemid 32436909)
26. Goldberg A, Confino-Cohen R. Timing of venom skin tests and IgE determinations after insect sting anaphylaxis. J Allergy Clin Immunol 1997;100:182-4. (Pubitemid 27349858)
27. Golden DBK, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Insect sting allergy with negative venom skin test responses. J Allergy Clin Immunol 2001;107:897-901. (Pubitemid 32436925)
28. Golden DBK, Tracy JM, Freeman TM, Hoffman DR. Negative venom skin test results in patients with histories of systemic reaction to a sting. J Allergy Clin Immunol 2003;112:495-8. (Pubitemid 37108551)
29. Golden DBK, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 2004;351:668-74.
30. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990; 323:1601-3.
31. Golden DBK, Kelly D, Hamilton RG, Craig TJ. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 2009;123:1371-5.
32. Severino MG, Cortellini G, Bonadonna P, et al. Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial. J Allergy Clin Immunol 2008;122: 44-8.
33. Ruëff F, Wenderoth A, Przybilla B. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 2001;108:1027-32.
34. Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U. Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005;60:1459-70. (Pubitemid 41654315)
35. Committee on Insects. The discontinuation of Hymenoptera venom immunotherapy. J Allergy Clin Immunol 1998;101: 573-5.
36. Forester JP, Johnson TL, Arora R, Quinn JM. Systemic reaction rates to field stings among imported fire ant-sensitive patients receiving >3 years of immunotherapy versus <3 years of immunotherapy. Allergy Asthma Proc 2007;28:485-8.
37. Golden DBK, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol 1996;97:579-87. (Pubitemid 26062755)
38. Golden DBK, Kwiterovich KA, Kagey-Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: extended observations. J Allergy Clin Immunol 1998;101: 298-305. (Pubitemid 28146345)
39. Golden DBK, Kagey-Sobotka A, Lichtenstein LM. Survey of patients after discontinuing venom immunotherapy. J Allergy Clin Immunol 2000;105:385-90. (Pubitemid 30109056)
40. Hafner T, DuBuske L, Kosnik M. Long-term efficacy of venom immunotherapy. Ann Allergy Asthma Immunol 2008;100:162-5. (Pubitemid 351238552)
41. Haugaard L, Nørregaard OFH, Dahl R. In-hospital sting challenge in insect venomallergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 1991;87:699-702.
42. Lerch E, Müller UR. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol 1998;101: 606-12.
43. Müller U, Berchtold E, Helbling A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 1991;87: 702-9.
44. Reisman RE. Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol 1993; 92:831-6. (Pubitemid 23361623)
45. Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 1991;88:339-48.
46. Moffitt JE, Barker JR, Stafford CT. Management of imported fire ant allergy: results of a survey. Ann Allergy Asthma Immunol 1997;79:125-30. (Pubitemid 27375285)